Ionomycin inhibits Jurkat T cell behaviors in the presence of phorbol-12,13-dibutyrate

Annals of Hematology

Volumn 93, Issue 5, 2014, Pages 735-746

  Wang, Yuan ^a   Hao, Wenting ^a   Xing, Rui ^b   Di, Jingfang ^a   Zeng, Shan ^a   Liu, Jing ^a   Xing, Feiyue ^a  

^a JINAN UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

Biologic behavior; Ionomycin; Jurkat T cell; Phorbol 12,13 dibutyrate

Indexed keywords

CALCIUM ION; CASPASE 3; IONOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHORBOL DIBUTYRATE; TRANSFORMING GROWTH FACTOR BETA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER INHIBITION; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL FUNCTION; CELL PH; CELL STIMULATION; COLONY FORMATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

APOPTOSIS; CALCIUM; CALCIUM IONOPHORES; CASPASE 3; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; HYDROGEN-ION CONCENTRATION; IONOMYCIN; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHORBOL 12,13-DIBUTYRATE; S PHASE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84898845313     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1955-2     Document Type: Article

References (31)

1. Liu C, Hermann TE (1978) Characterization of ionomycin as a calcium ionophore. J Biol Chem 253:5892-5894
2. Purkiss JR, Willars GB (1996) Ionomycin induced changes in intracellular free calcium in SH-SY5Y human neuroblastoma cells: sources of calcium and effects on [3H]-noradrenaline release. Cell Calcium 20:21-29
3. Ding R, Tang J, Gao H, Li T, Zhou H et al (2012) New methymycin derivatives of Streptomyces venezuelae ATCC 15439 and their inhibitory effects on human T cell proliferation mediated by PMA/ionomycin. Arch Pharm Res 35:1567-1572
4. Gao M, Jin W, Qian Y, Ji L, Feng G et al (2011) Effect of N-methyl-d-aspartate receptor antagonist on T helper cell differentiation induced by phorbol-myristate-acetate and ionomycin. Cytokine 56:458-465
5. Stankov K, Bogdanovic G, Stankov S, Draskovic D, Grubor-Lajsic G et al (2012) Expression analysis of genes involved in apoptosis, proliferation and endoplasmic reticulum stress in ionomycin/PMA treated Jurkat cells. J BUON 17:369-376
6. Park HJ, Makepeace CM, Lyons JC, Song CW (1996) Effect of intracellular acidity and ionomycin on apoptosis in HL-60 cells. Eur J Cancer 32A:540-546
7. Abraham RT, Weiss A (2004) Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat Rev Immunol 4:301-308
8. Guegan JP, Fremin C, Baffet G (2012) The MAPK MEK1/2-ERK1/2 pathway and its implication in hepatocyte cell cycle control. Int J Hepatol 2012:328372
9. Meloche S, Pouysségur J (2007) The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26:3227-3239
10. Parra E (2011) Activation of MAP kinase family members triggered by TPA or ionomycin occurs via the protein phosphatase 4 pathway in Jurkat leukemia T cells. Mol Med Rep 5:773-778
11. Piek E, Heldin CH, Ten Dijke P (1999) Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 13:2105-2124
12. Ring CJ, Cho KW (1999) Insights from model systems specificity in transforming growth factor-beta signaling pathways. Am J Hum Genet 64:691-697
13. Song BC, Chung YH, Kim JA et al (2002) Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma. Cancer 94:175-180
14. Lin CM, Wang FH, Lee PK (2002) Activated human CD4(+) T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-beta: Implications for dendritic cell immunization against cancer. Clin Immunol 102:96-105
15. Massagué J (2008) TGFβ in cancer. Cell 134:215-230
16. Decker P, Muller S (2002) Modulating poly(ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress. Curr Pharm Biotechnol 3:275-283
17. Yoshida H, Hirono C, Shimamoto C, Daikoku E, Kubota T et al (2010) Membrane potential modulation of ionomycin-stimulated Ca(2+) entry via Ca (2+)/H (+) exchange and SOC in rat submandibular acinar cells. J Physiol Sci 60:363-371
18. Berridge MJ, Bootman MD, Roderick HL (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4:517-529
19. Rizzuto R, Pinton P, Ferrari D et al (2003) Calcium and apoptosis: facts and hypotheses. Oncogene 22:8619-8627
20. Orrenius S, Zhivotovsky B, Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4:552-565
21. Khadra N, Bresson-Bepoldin L, Penna A et al (2011) CD95 triggers Orai1-mediated localized Ca2+ entry, regulates recruitment of protein kinase C (PKC) beta2, and prevents death-inducing signaling complex formation. Proc Natl Acad Sci U S A 108:19072-19077
22. Mukherjee S, Trice J, Shinde P, Willis RE, Pressley TA et al (2013) Ca2+ oscillations, Ca2+ sensitization, and contraction activated by protein kinase C in small airway smooth muscle. J Gen Physiol 141:165-178
23. Rivera J (2002) Molecular adapters in FcεRI signaling and the allergic response. Curr Opin Immunol 14:688-693
24. Abdel-Raheem IT, Hide I, Yanase Y et al (2005) Protein kinase C-alpha mediates TNF release process in RBL-2H3 mast cells. Br J Pharmacol 145:415-423
25. Hanson DA, Ziegler SF (2002) Regulation of ionomycin-mediated granule release from rat basophil leukemia cells. Mol Immunol 38:1329-1335
26. Aggarwal BB, Shishodia S, Ashikawa K, Bharti AC (2002) The role of TNF and its family members in inflammation and cancer: lessons from gene deletion. Curr Drug Targets Inflamm Allergy 1:327-341
27. Pfeffer K (2003) Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev 14:185-191
28. Borst SE (2004) The role of TNF-alpha in insulin resistance. Endocrine 23:177-182
29. Vermeulen MA, de Jong J, Vaessen MJ, van Leeuwen PA, Houdijk AP (2011) Glutamate reduces experimental intestinal hyperpermeability and facilitates glutamine support of gut integrity. World J Gastroenterol 17:1569-1573
30. Maish MS, Carballo M, Yetasook A (2011) Phorbol 12,13 dibutyrate behaves in a tumor-inhibitory manner in esophageal adenocarcinoma cell lines. Dis Esophagus 24:611-616
31. Trump BF, Berezesky IK (1995) Calcium-mediated cell injury and cell death. FASEB J 9:219-228